$3.49
0.082.35%
At close: -
$3.50
0.010000.29%
After Hours: Dec 20, 7:56 PM EDT
Comments
Loading...
Xeris Biopharma Holdings (XERS) Forecast
NewsEarningsXeris Biopharma Holdings (XERS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestXeris Biopharma Holdings (NASDAQ:XERS) Stock Quotes, Forecast and News Summary
Xeris Biopharma Holdings Stock (NASDAQ: XERS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Xeris Biopharma Holdings (XERS) stock?
You can purchase shares of Xeris Biopharma Holdings (NASDAQ:XERS) through any online brokerage.
Who are Xeris Biopharma Holdings (XERS) competitors?
Other companies in Xeris Biopharma Holdings’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
What is the forecast, or price target, for Xeris Biopharma Holdings (XERS) stock?
Xeris Biopharma Holdings has a consensus price target of $4.87.
What is the current price for Xeris Biopharma Holdings (XERS)?
The stock price for Xeris Biopharma Holdings (NASDAQ: XERS) is $3.5 last updated December 20, 2024 at 7:56 PM EST.
Does Xeris Biopharma Holdings (XERS) pay a dividend?
There are no upcoming dividends for Xeris Biopharma Holdings.
When is Xeris Biopharma Holdings (NASDAQ:XERS) reporting earnings?
Xeris Biopharma Holdings’s Q4 earnings are confirmed for Wednesday, March 5, 2025.
Is Xeris Biopharma Holdings (XERS) going to split?
There is no upcoming split for Xeris Biopharma Holdings.
What sector and industry does Xeris Biopharma Holdings (XERS) operate in?
Xeris Biopharma Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.